Digital health technologies are reshaping respiratory medicine, from home-based monitoring in chronic lung disease to ...

Please provide your email address to receive an email when new articles are posted on . Use of decentralized elements in cancer clinical trials did not have long-term negative effects on data quality.

The global virtual clinical trials market is set to witness a growth rate of ~6% in the next 5 years. Rising adoption of decentralized trial models, advancements in digital health technologies, ...

Paul Shawah, EVP, strategy, Veeva Systems and Richard Staub, president, R&D solutions, IQVIA, explain how their partnership is improving efficiency and data management in clinical trials by ...

By integrating digital tools like ePRO, we can bridge the gap between patients’ lived experiences and clinical research.

Paul Shawah, EVP, strategy, Veeva Systems and Richard Staub, president, R&D solutions, IQVIA, explain how their partnership ...

LONG BEACH, Calif.--(BUSINESS WIRE)--Ark Clinical Research (“Ark”) is set to unveil a cutting-edge mobile unit in early 2025, revolutionizing the way clinical trials are conducted. This strategic ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions and clinical research services to the healthcare and life ...

The first technology-enabled remote clinical trial was launched nearly a decade ago, and that field – now generally referred to as "decentralized clinical trials" – has been advancing and gaining ...

Decentralized clinical trials, which gained popularity during the COVID-19 pandemic, are clinical trial studies that use telemedicine and mobile technologies to perform trial activities outside of a ...